Global Gravid Treatment Market Insights and Forecast to 2028

  • Report ID:224913
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 111
                              
Gravid Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Gravid Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Topical Products Lasers Microdermabrasion Others Segment by Application Hospitals Clinics Specialty Dermatology Centers Home-use Others By Company Laboratoires Expanscience Clarins Group Merz North America, Inc. (Merz Group) E.T. Browne Drug Cynosure Syneron Medical Ltd. Union-Swiss (Pty) Ltd. Basq Skincare Ellipse A/S The Boppy Company Helix BioMedix Weleda AG Dermaclara Mama Mio US Centre Light Solutions By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gravid Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Topical Products 1.2.3 Lasers 1.2.4 Microdermabrasion 1.2.5 Others 1.3 Market by Application 1.3.1 Global Gravid Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Specialty Dermatology Centers 1.3.5 Home-use 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gravid Treatment Market Perspective (2017-2028) 2.2 Gravid Treatment Growth Trends by Region 2.2.1 Gravid Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Gravid Treatment Historic Market Size by Region (2017-2022) 2.2.3 Gravid Treatment Forecasted Market Size by Region (2023-2028) 2.3 Gravid Treatment Market Dynamics 2.3.1 Gravid Treatment Industry Trends 2.3.2 Gravid Treatment Market Drivers 2.3.3 Gravid Treatment Market Challenges 2.3.4 Gravid Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Gravid Treatment Players by Revenue 3.1.1 Global Top Gravid Treatment Players by Revenue (2017-2022) 3.1.2 Global Gravid Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Gravid Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Gravid Treatment Revenue 3.4 Global Gravid Treatment Market Concentration Ratio 3.4.1 Global Gravid Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gravid Treatment Revenue in 2021 3.5 Gravid Treatment Key Players Head office and Area Served 3.6 Key Players Gravid Treatment Product Solution and Service 3.7 Date of Enter into Gravid Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gravid Treatment Breakdown Data by Type 4.1 Global Gravid Treatment Historic Market Size by Type (2017-2022) 4.2 Global Gravid Treatment Forecasted Market Size by Type (2023-2028) 5 Gravid Treatment Breakdown Data by Application 5.1 Global Gravid Treatment Historic Market Size by Application (2017-2022) 5.2 Global Gravid Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Gravid Treatment Market Size (2017-2028) 6.2 North America Gravid Treatment Market Size by Type 6.2.1 North America Gravid Treatment Market Size by Type (2017-2022) 6.2.2 North America Gravid Treatment Market Size by Type (2023-2028) 6.2.3 North America Gravid Treatment Market Share by Type (2017-2028) 6.3 North America Gravid Treatment Market Size by Application 6.3.1 North America Gravid Treatment Market Size by Application (2017-2022) 6.3.2 North America Gravid Treatment Market Size by Application (2023-2028) 6.3.3 North America Gravid Treatment Market Share by Application (2017-2028) 6.4 North America Gravid Treatment Market Size by Country 6.4.1 North America Gravid Treatment Market Size by Country (2017-2022) 6.4.2 North America Gravid Treatment Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Gravid Treatment Market Size (2017-2028) 7.2 Europe Gravid Treatment Market Size by Type 7.2.1 Europe Gravid Treatment Market Size by Type (2017-2022) 7.2.2 Europe Gravid Treatment Market Size by Type (2023-2028) 7.2.3 Europe Gravid Treatment Market Share by Type (2017-2028) 7.3 Europe Gravid Treatment Market Size by Application 7.3.1 Europe Gravid Treatment Market Size by Application (2017-2022) 7.3.2 Europe Gravid Treatment Market Size by Application (2023-2028) 7.3.3 Europe Gravid Treatment Market Share by Application (2017-2028) 7.4 Europe Gravid Treatment Market Size by Country 7.4.1 Europe Gravid Treatment Market Size by Country (2017-2022) 7.4.2 Europe Gravid Treatment Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Gravid Treatment Market Size (2017-2028) 8.2 Asia-Pacific Gravid Treatment Market Size by Type 8.2.1 Asia-Pacific Gravid Treatment Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Gravid Treatment Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Gravid Treatment Market Share by Type (2017-2028) 8.3 Asia-Pacific Gravid Treatment Market Size by Application 8.3.1 Asia-Pacific Gravid Treatment Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Gravid Treatment Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Gravid Treatment Market Share by Application (2017-2028) 8.4 Asia-Pacific Gravid Treatment Market Size by Region 8.4.1 Asia-Pacific Gravid Treatment Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Gravid Treatment Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Gravid Treatment Market Size (2017-2028) 9.2 Latin America Gravid Treatment Market Size by Type 9.2.1 Latin America Gravid Treatment Market Size by Type (2017-2022) 9.2.2 Latin America Gravid Treatment Market Size by Type (2023-2028) 9.2.3 Latin America Gravid Treatment Market Share by Type (2017-2028) 9.3 Latin America Gravid Treatment Market Size by Application 9.3.1 Latin America Gravid Treatment Market Size by Application (2017-2022) 9.3.2 Latin America Gravid Treatment Market Size by Application (2023-2028) 9.3.3 Latin America Gravid Treatment Market Share by Application (2017-2028) 9.4 Latin America Gravid Treatment Market Size by Country 9.4.1 Latin America Gravid Treatment Market Size by Country (2017-2022) 9.4.2 Latin America Gravid Treatment Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Gravid Treatment Market Size (2017-2028) 10.2 Middle East & Africa Gravid Treatment Market Size by Type 10.2.1 Middle East & Africa Gravid Treatment Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Gravid Treatment Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Gravid Treatment Market Share by Type (2017-2028) 10.3 Middle East & Africa Gravid Treatment Market Size by Application 10.3.1 Middle East & Africa Gravid Treatment Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Gravid Treatment Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Gravid Treatment Market Share by Application (2017-2028) 10.4 Middle East & Africa Gravid Treatment Market Size by Country 10.4.1 Middle East & Africa Gravid Treatment Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Gravid Treatment Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Laboratoires Expanscience 11.1.1 Laboratoires Expanscience Company Details 11.1.2 Laboratoires Expanscience Business Overview 11.1.3 Laboratoires Expanscience Gravid Treatment Introduction 11.1.4 Laboratoires Expanscience Revenue in Gravid Treatment Business (2017-2022) 11.1.5 Laboratoires Expanscience Recent Developments 11.2 Clarins Group 11.2.1 Clarins Group Company Details 11.2.2 Clarins Group Business Overview 11.2.3 Clarins Group Gravid Treatment Introduction 11.2.4 Clarins Group Revenue in Gravid Treatment Business (2017-2022) 11.2.5 Clarins Group Recent Developments 11.3 Merz North America, Inc. (Merz Group) 11.3.1 Merz North America, Inc. (Merz Group) Company Details 11.3.2 Merz North America, Inc. (Merz Group) Business Overview 11.3.3 Merz North America, Inc. (Merz Group) Gravid Treatment Introduction 11.3.4 Merz North America, Inc. (Merz Group) Revenue in Gravid Treatment Business (2017-2022) 11.3.5 Merz North America, Inc. (Merz Group) Recent Developments 11.4 E.T. Browne Drug 11.4.1 E.T. Browne Drug Company Details 11.4.2 E.T. Browne Drug Business Overview 11.4.3 E.T. Browne Drug Gravid Treatment Introduction 11.4.4 E.T. Browne Drug Revenue in Gravid Treatment Business (2017-2022) 11.4.5 E.T. Browne Drug Recent Developments 11.5 Cynosure 11.5.1 Cynosure Company Details 11.5.2 Cynosure Business Overview 11.5.3 Cynosure Gravid Treatment Introduction 11.5.4 Cynosure Revenue in Gravid Treatment Business (2017-2022) 11.5.5 Cynosure Recent Developments 11.6 Syneron Medical Ltd. 11.6.1 Syneron Medical Ltd. Company Details 11.6.2 Syneron Medical Ltd. Business Overview 11.6.3 Syneron Medical Ltd. Gravid Treatment Introduction 11.6.4 Syneron Medical Ltd. Revenue in Gravid Treatment Business (2017-2022) 11.6.5 Syneron Medical Ltd. Recent Developments 11.7 Union-Swiss (Pty) Ltd. 11.7.1 Union-Swiss (Pty) Ltd. Company Details 11.7.2 Union-Swiss (Pty) Ltd. Business Overview 11.7.3 Union-Swiss (Pty) Ltd. Gravid Treatment Introduction 11.7.4 Union-Swiss (Pty) Ltd. Revenue in Gravid Treatment Business (2017-2022) 11.7.5 Union-Swiss (Pty) Ltd. Recent Developments 11.8 Basq Skincare 11.8.1 Basq Skincare Company Details 11.8.2 Basq Skincare Business Overview 11.8.3 Basq Skincare Gravid Treatment Introduction 11.8.4 Basq Skincare Revenue in Gravid Treatment Business (2017-2022) 11.8.5 Basq Skincare Recent Developments 11.9 Ellipse A/S 11.9.1 Ellipse A/S Company Details 11.9.2 Ellipse A/S Business Overview 11.9.3 Ellipse A/S Gravid Treatment Introduction 11.9.4 Ellipse A/S Revenue in Gravid Treatment Business (2017-2022) 11.9.5 Ellipse A/S Recent Developments 11.10 The Boppy Company 11.10.1 The Boppy Company Company Details 11.10.2 The Boppy Company Business Overview 11.10.3 The Boppy Company Gravid Treatment Introduction 11.10.4 The Boppy Company Revenue in Gravid Treatment Business (2017-2022) 11.10.5 The Boppy Company Recent Developments 11.11 Helix BioMedix 11.11.1 Helix BioMedix Company Details 11.11.2 Helix BioMedix Business Overview 11.11.3 Helix BioMedix Gravid Treatment Introduction 11.11.4 Helix BioMedix Revenue in Gravid Treatment Business (2017-2022) 11.11.5 Helix BioMedix Recent Developments 11.12 Weleda AG 11.12.1 Weleda AG Company Details 11.12.2 Weleda AG Business Overview 11.12.3 Weleda AG Gravid Treatment Introduction 11.12.4 Weleda AG Revenue in Gravid Treatment Business (2017-2022) 11.12.5 Weleda AG Recent Developments 11.13 Dermaclara 11.13.1 Dermaclara Company Details 11.13.2 Dermaclara Business Overview 11.13.3 Dermaclara Gravid Treatment Introduction 11.13.4 Dermaclara Revenue in Gravid Treatment Business (2017-2022) 11.13.5 Dermaclara Recent Developments 11.14 Mama Mio US 11.14.1 Mama Mio US Company Details 11.14.2 Mama Mio US Business Overview 11.14.3 Mama Mio US Gravid Treatment Introduction 11.14.4 Mama Mio US Revenue in Gravid Treatment Business (2017-2022) 11.14.5 Mama Mio US Recent Developments 11.15 Centre Light Solutions 11.15.1 Centre Light Solutions Company Details 11.15.2 Centre Light Solutions Business Overview 11.15.3 Centre Light Solutions Gravid Treatment Introduction 11.15.4 Centre Light Solutions Revenue in Gravid Treatment Business (2017-2022) 11.15.5 Centre Light Solutions Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global Gravid Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Topical Products Table 3. Key Players of Lasers Table 4. Key Players of Microdermabrasion Table 5. Key Players of Others Table 6. Global Gravid Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global Gravid Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Gravid Treatment Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Gravid Treatment Market Share by Region (2017-2022) Table 10. Global Gravid Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Gravid Treatment Market Share by Region (2023-2028) Table 12. Gravid Treatment Market Trends Table 13. Gravid Treatment Market Drivers Table 14. Gravid Treatment Market Challenges Table 15. Gravid Treatment Market Restraints Table 16. Global Gravid Treatment Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Gravid Treatment Revenue Share by Players (2017-2022) Table 18. Global Top Gravid Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gravid Treatment as of 2021) Table 19. Ranking of Global Top Gravid Treatment Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Gravid Treatment Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Gravid Treatment Product Solution and Service Table 23. Date of Enter into Gravid Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Gravid Treatment Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Gravid Treatment Revenue Market Share by Type (2017-2022) Table 27. Global Gravid Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Gravid Treatment Revenue Market Share by Type (2023-2028) Table 29. Global Gravid Treatment Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Gravid Treatment Revenue Share by Application (2017-2022) Table 31. Global Gravid Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Gravid Treatment Revenue Share by Application (2023-2028) Table 33. North America Gravid Treatment Market Size by Type (2017-2022) & (US$ Million) Table 34. North America Gravid Treatment Market Size by Type (2023-2028) & (US$ Million) Table 35. North America Gravid Treatment Market Size by Application (2017-2022) & (US$ Million) Table 36. North America Gravid Treatment Market Size by Application (2023-2028) & (US$ Million) Table 37. North America Gravid Treatment Market Size by Country (2017-2022) & (US$ Million) Table 38. North America Gravid Treatment Market Size by Country (2023-2028) & (US$ Million) Table 39. Europe Gravid Treatment Market Size by Type (2017-2022) & (US$ Million) Table 40. Europe Gravid Treatment Market Size by Type (2023-2028) & (US$ Million) Table 41. Europe Gravid Treatment Market Size by Application (2017-2022) & (US$ Million) Table 42. Europe Gravid Treatment Market Size by Application (2023-2028) & (US$ Million) Table 43. Europe Gravid Treatment Market Size by Country (2017-2022) & (US$ Million) Table 44. Europe Gravid Treatment Market Size by Country (2023-2028) & (US$ Million) Table 45. Asia Pacific Gravid Treatment Market Size by Type (2017-2022) & (US$ Million) Table 46. Asia Pacific Gravid Treatment Market Size by Type (2023-2028) & (US$ Million) Table 47. Asia Pacific Gravid Treatment Market Size by Application (2017-2022) & (US$ Million) Table 48. Asia Pacific Gravid Treatment Market Size by Application (2023-2028) & (US$ Million) Table 49. Asia Pacific Gravid Treatment Market Size by Region (2017-2022) & (US$ Million) Table 50. Asia Pacific Gravid Treatment Market Size by Region (2023-2028) & (US$ Million) Table 51. Latin America Gravid Treatment Market Size by Type (2017-2022) & (US$ Million) Table 52. Latin America Gravid Treatment Market Size by Type (2023-2028) & (US$ Million) Table 53. Latin America Gravid Treatment Market Size by Application (2017-2022) & (US$ Million) Table 54. Latin America Gravid Treatment Market Size by Application (2023-2028) & (US$ Million) Table 55. Latin America Gravid Treatment Market Size by Country (2017-2022) & (US$ Million) Table 56. Latin America Gravid Treatment Market Size by Country (2023-2028) & (US$ Million) Table 57. Middle East and Africa Gravid Treatment Market Size by Type (2017-2022) & (US$ Million) Table 58. Middle East and Africa Gravid Treatment Market Size by Type (2023-2028) & (US$ Million) Table 59. Middle East and Africa Gravid Treatment Market Size by Application (2017-2022) & (US$ Million) Table 60. Middle East and Africa Gravid Treatment Market Size by Application (2023-2028) & (US$ Million) Table 61. Middle East and Africa Gravid Treatment Market Size by Country (2017-2022) & (US$ Million) Table 62. Middle East and Africa Gravid Treatment Market Size by Country (2023-2028) & (US$ Million) Table 63. Laboratoires Expanscience Company Details Table 64. Laboratoires Expanscience Business Overview Table 65. Laboratoires Expanscience Gravid Treatment Product Table 66. Laboratoires Expanscience Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 67. Laboratoires Expanscience Recent Developments Table 68. Clarins Group Company Details Table 69. Clarins Group Business Overview Table 70. Clarins Group Gravid Treatment Product Table 71. Clarins Group Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 72. Clarins Group Recent Developments Table 73. Merz North America, Inc. (Merz Group) Company Details Table 74. Merz North America, Inc. (Merz Group) Business Overview Table 75. Merz North America, Inc. (Merz Group) Gravid Treatment Product Table 76. Merz North America, Inc. (Merz Group) Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 77. Merz North America, Inc. (Merz Group) Recent Developments Table 78. E.T. Browne Drug Company Details Table 79. E.T. Browne Drug Business Overview Table 80. E.T. Browne Drug Gravid Treatment Product Table 81. E.T. Browne Drug Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 82. E.T. Browne Drug Recent Developments Table 83. Cynosure Company Details Table 84. Cynosure Business Overview Table 85. Cynosure Gravid Treatment Product Table 86. Cynosure Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 87. Cynosure Recent Developments Table 88. Syneron Medical Ltd. Company Details Table 89. Syneron Medical Ltd. Business Overview Table 90. Syneron Medical Ltd. Gravid Treatment Product Table 91. Syneron Medical Ltd. Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 92. Syneron Medical Ltd. Recent Developments Table 93. Union-Swiss (Pty) Ltd. Company Details Table 94. Union-Swiss (Pty) Ltd. Business Overview Table 95. Union-Swiss (Pty) Ltd. Gravid Treatment Product Table 96. Union-Swiss (Pty) Ltd. Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 97. Union-Swiss (Pty) Ltd. Recent Developments Table 98. Basq Skincare Company Details Table 99. Basq Skincare Business Overview Table 100. Basq Skincare Gravid Treatment Product Table 101. Basq Skincare Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 102. Basq Skincare Recent Developments Table 103. Ellipse A/S Company Details Table 104. Ellipse A/S Business Overview Table 105. Ellipse A/S Gravid Treatment Product Table 106. Ellipse A/S Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 107. Ellipse A/S Recent Developments Table 108. The Boppy Company Company Details Table 109. The Boppy Company Business Overview Table 110. The Boppy Company Gravid Treatment Product Table 111. The Boppy Company Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 112. The Boppy Company Recent Developments Table 113. Helix BioMedix Company Details Table 114. Helix BioMedix Business Overview Table 115. Helix BioMedix Gravid Treatment Product Table 116. Helix BioMedix Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 117. Helix BioMedix Recent Developments Table 118. Weleda AG Company Details Table 119. Weleda AG Business Overview Table 120. Weleda AG Gravid Treatment Product Table 121. Weleda AG Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 122. Weleda AG Recent Developments Table 123. Dermaclara Company Details Table 124. Dermaclara Business Overview Table 125. Dermaclara Gravid Treatment Product Table 126. Dermaclara Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 127. Dermaclara Recent Developments Table 128. Mama Mio US Company Details Table 129. Mama Mio US Business Overview Table 130. Mama Mio US Gravid Treatment Product Table 131. Mama Mio US Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 132. Mama Mio US Recent Developments Table 133. Centre Light Solutions Company Details Table 134. Centre Light Solutions Business Overview Table 135. Centre Light Solutions Gravid Treatment Product Table 136. Centre Light Solutions Revenue in Gravid Treatment Business (2017-2022) & (US$ Million) Table 137. Centre Light Solutions Recent Developments Table 138. Research Programs/Design for This Report Table 139. Key Data Information from Secondary Sources Table 140. Key Data Information from Primary Sources List of Figures Figure 1. Global Gravid Treatment Market Share by Type: 2021 VS 2028 Figure 2. Topical Products Features Figure 3. Lasers Features Figure 4. Microdermabrasion Features Figure 5. Others Features Figure 6. Global Gravid Treatment Market Share by Application: 2021 VS 2028 Figure 7. Hospitals Case Studies Figure 8. Clinics Case Studies Figure 9. Specialty Dermatology Centers Case Studies Figure 10. Home-use Case Studies Figure 11. Others Case Studies Figure 12. Gravid Treatment Report Years Considered Figure 13. Global Gravid Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global Gravid Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Gravid Treatment Market Share by Region: 2021 VS 2028 Figure 16. Global Gravid Treatment Market Share by Players in 2021 Figure 17. Global Top Gravid Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gravid Treatment as of 2021) Figure 18. The Top 10 and 5 Players Market Share by Gravid Treatment Revenue in 2021 Figure 19. North America Gravid Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 20. North America Gravid Treatment Market Size Market Share by Type (2017-2028) Figure 21. North America Gravid Treatment Market Size Market Share by Application (2017-2028) Figure 22. North America Gravid Treatment Market Size Share by Country (2017-2028) Figure 23. United States Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Canada Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Europe Gravid Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 26. Europe Gravid Treatment Market Size Market Share by Type (2017-2028) Figure 27. Europe Gravid Treatment Market Size Market Share by Application (2017-2028) Figure 28. Europe Gravid Treatment Market Size Share by Country (2017-2028) Figure 29. Germany Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. France Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. U.K. Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Italy Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Russia Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Nordic Countries Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Gravid Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 36. Asia Pacific Gravid Treatment Market Size Market Share by Type (2017-2028) Figure 37. Asia Pacific Gravid Treatment Market Size Market Share by Application (2017-2028) Figure 38. Asia Pacific Gravid Treatment Market Size Share by Region (2017-2028) Figure 39. China Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Japan Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. South Korea Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Southeast Asia Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. India Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Australia Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 45. Latin America Gravid Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 46. Latin America Gravid Treatment Market Size Market Share by Type (2017-2028) Figure 47. Latin America Gravid Treatment Market Size Market Share by Application (2017-2028) Figure 48. Latin America Gravid Treatment Market Size Share by Country (2017-2028) Figure 49. Mexico Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Brazil Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Middle East & Africa Gravid Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 52. Middle East and Africa Gravid Treatment Market Size Market Share by Type (2017-2028) Figure 53. Middle East and Africa Gravid Treatment Market Size Market Share by Application (2017-2028) Figure 54. Middle East and Africa Gravid Treatment Market Size Share by Country (2017-2028) Figure 55. Turkey Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Saudi Arabia Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. UAE Gravid Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 58. Laboratoires Expanscience Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 59. Clarins Group Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 60. Merz North America, Inc. (Merz Group) Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 61. E.T. Browne Drug Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 62. Cynosure Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 63. Syneron Medical Ltd. Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 64. Union-Swiss (Pty) Ltd. Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 65. Basq Skincare Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 66. Ellipse A/S Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 67. The Boppy Company Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 68. Helix BioMedix Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 69. Weleda AG Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 70. Dermaclara Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 71. Mama Mio US Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 72. Centre Light Solutions Revenue Growth Rate in Gravid Treatment Business (2017-2022) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.